NCT05514717 2025-07-11A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2Mersana TherapeuticsPhase 1 Recruiting162 enrolled
NCT05511844 2025-07-04Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid TumorsOrum Therapeutics USA, Inc.Phase 1 Terminated25 enrolled
NCT04332588 2025-05-29Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRIUniversity of Alabama at BirminghamPhase 1 Recruiting25 enrolled